The FDA published a statement on their progress regarding a path to a regulated CBD marketplace. They also issued an update to Congress about enforcement actions, education, regulatory policy and a timeframe. Most notably, the report provides some insight to their regulatory approach, including mention of treating CBD products like a dietary supplement.
Source Cannabis Industry Journal
This news is provided by Cannabis Industry Journal RSS Feed, All credits go to Cannabis Industry Journal. For more Cannabis Industry Journal News please visit: https://cannabisindustryjournal.com/
Disclaimer: All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. The author is not paid to share this information. Cannabis Investment Group is not paid to share this information and has no business relationship other than shareholder with any company whose stock is mentioned in this article.